Pia Aehnlich

Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens

E. Noessner, B. Moser, Ö. Met, 2021, Frontiers in Immunology.

The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56.

S. R. Pedersen, I. Svane, P. thor Straten, 2021, Cytotherapy.

Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression

H. Hasselbalch, P. thor Straten, S. Vidal, 2022, Frontiers in Immunology.

Mitochondrial-Linked De Novo Pyrimidine Biosynthesis Dictates Human T-Cell Proliferation but Not Expression of Effector Molecules

L. Rasmussen, Ö. Met, P. thor Straten, 2021, Frontiers in Immunology.

TAM Receptor Inhibition–Implications for Cancer and the Immune System

P. thor Straten, Marlies J. W. Peeters, Pia Aehnlich, 2021, Cancers.

Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells

P. thor Straten, Marlies J. W. Peeters, T. Seremet, 2021, Vaccines.

Expansion With IL-15 Increases Cytotoxicity of Vγ9Vδ2 T Cells and Is Associated With Higher Levels of Cytotoxic Molecules and T-bet

P. thor Straten, Gitte Holmen Olofsson, Ana Micaela Carnaz Simões, 2020, Frontiers in Immunology.

764 Expansion with IL-15 increases cytotoxicity of Vγ9Vδ2 T cells and is associated with higher levels of cytotoxic molecules and T-bet

P. Straten, Alberto Simões, Pia Aehnlich, 2020 .

Glycolysis inhibition affects proliferation and cytotoxicity of Vγ9Vδ2 T cells expanded for adoptive cell therapy.

Gitte Holmen Olofsson, Pia Aehnlich, Anne Rahbech, 2024, Cytotherapy.